SHIP deficiency causes Crohn's disease-like ileitis by Kerr, William G et al.
SHIP deﬁciency causes Crohn’s disease-like ileitis
William G Kerr,
1,2 Mi-Young Park,
1 Monique Maubert,
1 Robert W Engelman
3
ABSTRACT
Background Inﬂammatory bowel disease (IBD) can arise
from genetic mutations that compromise intestinal
epithelial cell integrity or immune regulation. SHIP has
previously been shown to play a pivotal role in limiting
the number of immunoregulatory cells and their function.
Aim To determine whether SHIP plays a pivotal role in
control of immune tolerance in the gut mucosa.
Methods Gastrointestinal pathology was assessed in
three separate strains of SHIP-deﬁcient mice and their
respective wild-type (WT) littermates. Gastrointestinal
pathology was analysed in SHIP-deﬁcient hosts
reconstituted with WT haematopoietic cell grafts, and
WT hosts reconstituted with SHIP-deﬁcient
haematopoietic cell grafts including whole splenocytes,
puriﬁed T cells or natural killer (NK) cells. Major immune
cell populations were also analysed in the small intestine
of SHIP-deﬁcient mice and WT controls.
Results SHIP-deﬁcient mice developed segmental,
transmural pyo-granulomatous ilietis that recapitulated
classical features of Crohn’s disease enteric pathology.
Analysis of haematopoietic chimeras showed that WT
bone marrow reconstitution of SHIP
 /  hosts corrects
ileitis. Reconstitution with SHIP
 /  splenocytes
transferred ileitis to WT hosts. Adoptive transfer of
puriﬁed SHIP
 /  T cells or NK cells to WT hosts did not
transfer ileitis. There was a paucity of both CD4 and CD8
T cells in the small intestines of SHIP-deﬁcient mice;
however, neutrophil numbers were signiﬁcantly
increased.
Conclusions SHIP plays a pivotal role in immune
function in the intestine; further scrutiny of this pathway
in IBD patients is warranted. It is proposed that
SHIP-deﬁcient ileitis results from a local deﬁcit in
mucosal T cell immunity that promotes a damaging
granulocyteemonocyte inﬂammation of the distal ileum.
INTRODUCTION
Crohn’s disease (CD) is a chronic, relapsing idio-
pathic inﬂammatory bowel disease (IBD) that can
affect various sites within the gastrointestinal
tract, but classically the ileum, which leads to
abdominal cramping, diarrhoea and gastrointestinal
bleeding.
1e4 CD histopathological lesions begin
with the formation of multiple aphthoid ulcers
inﬁltrated by neutrophils, which progress and
coalesce into sharply delimited, regional, trans-
mural inﬂammations with granuloma formation,
thickening of the muscularis propria, strictures,
ﬁssures and ﬁstulas.
1e4 Although genome-wide
association studies have identiﬁed more than 30
susceptibility loci for IBD that disturb either
intestinal epithelial cell (IEC) barrier homeostasis or
immune effector cell functions and interactions
with luminal ﬂora and antigens,
5e7 many suscep-
tibility genes possess differing functions in IEC and
haematopoietic cells, and primary IEC or immuno-
logical defects in genetically susceptible individuals
often remain enigmatic.
89
Primary immunological alterations proposed to
contribute to the development of CD pathology
include increased expression of Th1-polarising
cytokines interleukin (IL)-12 and interferon g by
cells in the lamina propria,
10 11 aberrant IL-23-
initiated Th17-associated immune responses,
12 13
defects in regulatory T cell (Treg) modulation of
effector functions via transforming growth factor
b or IL-10 dependent mechanisms,
14 aberrant B-cell
speciﬁcity and serum autoreactivity
15 and myeloid
cell dysfunction.
16 That primary defects in immune
cell function contribute to CD in some patients is
supported by reports of disease remission following
allogeneic bone marrow transplantation.
17
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Signiﬁcance of this study
What is already known about this subject?
< Immune regulation is critical for the integrity and
function of the small intestine.
< SHIP controls the homeostasis of immunoregu-
latory myeloid and T lymphoid cells in peripheral
lymphoid tissues such as spleen and lymph
node.
< Myeloid consolidation of the lungs is a signiﬁcant
cause of morbidity and mortality in SHIP-
deﬁcient mice.
What are the new ﬁndings?
< Despite enhanced immune regulation in the
peripheral lymphoid tissues of SHIP-deﬁcient
mice, immune function and regulation is compro-
mised in the small intestine of these mice.
< Normal immune function and homeostasis in the
small intestine requires enzymatically active SHIP.
< Expression of SHIP by intestinal epithelial cells
is not required for the integrity of the small
intestine.
< SHIP-deﬁcient haematolymphoid cells are sufﬁ-
cient to transfer ileitis to wild-type hosts.
< There is a paucity of both CD4 and CD8 T cells in
the small intestine of SHIP-deﬁcient mice.
< There is local neutrophilia in the small intestines
of SHIP-deﬁcient mice.
How might it impact on clinical practice in the
foreseeable future?
< These ﬁndings suggest that detailed analysis of
the SHIP gene is warranted in human IBD
patients and may also lead to a better under-
standing of immune cell signalling pathways
required for immune function and regulation in
the human gut.
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Inﬂammatory bowel diseaseIEC barrier defects that may contribute to CD development
include the inability of a Paneth cell-derived NOD2 variant to
expel luminal bacteria,
18 diminished IEC autophagy and antimi-
crobial granule exocytosis,
19 altered IEC toll-like receptor expres-
sionwithpotentiallydysregulatedresponsestocommonbacterial
motifs,
20 altered IEC cytokine expression
21 and increased IEC
paracellularpermeabilitytoentericluminalcontents,perhapsdue
to inadequate formation of IEC tight junctions.
22
Although animal models of IBD have been described, most
model systems affect the large intestine, do not manifest
CD-speciﬁc histopathological features, and are often induced
rather than spontaneously developing models.
5 72 3Only two
animal models spontaneously develop chronic inﬂammation of
the ileum, the SAMP1/Yit mouse
24 and the TNF
ΔARE mouse.
25
SAMP1/Yit mice spontaneously develop terminal ileitis by
10 weeks of age driven by Th1- and Th2-type immune
responses, the severity of which can be decreased by anti-
tumour necrosis factor (TNF) antibodies.
23 26 27 Although
SAMP1/Yit mesenteric lymph node CD4
+ Tcells are capable of
adoptively transferring ileitis to severe combined immunodeﬁ-
cient (SCID) mice, increased IEC paracellular permeability
appears to be the primary susceptibility factor in this model.
22
The TNF
ΔARE mouse model was generated by deletion of 69bp
within the AU-rich region (ARE) of the gene that encodes TNF,
resulting in increased systemic TNF levels associated with
expansion of CD8
+ effector cell subpopulations that mediate
chronic ileitis and arthritis in both heterozygous and homozy-
gous mice.
25 28 Haematopoietic cells of neither the SAMP1/Yit
nor the TNF
ΔARE mouse are capable of adoptively transferring
CD-like disease to an immunocompetent host.
The Src homology 2 (SH2)-containing inositol-5-phosphatase
(SHIP) protein becomes tyrosine phosphorylated in haemato-
poietic cells following activation of surface receptors for various
cytokines including erythropoietin, IL-3, GM-CSF, M-CSF, or in
response to B cell antigen receptor cross-linking, or T cell acti-
vation.
29 30 SHIP signalling plays a pivotal role in limiting the
number and function of immunoregulatory cells in the periph-
eral lymphoid system.
31e37 We recently found that SHIP limits
the number of immunoregulatory T cells present in the spleen
and mesenteric lymph nodes.
35 SHIP performs this role by
controlling the number of Treg cells in the periphery either by
limiting the survival of FoxP3
+ Treg cells or by preventing the
inappropriate acquisition of FoxP3 expression by naïve CD4 T
cells.
35 Consistent with this ﬁnding, the p110 subunit of an
enzyme that SHIP opposes, PI3K, is critical for the formation
and survival of Treg cells in the periphery.
38 39 SHIP-deﬁciency
also promotes the inappropriate expansion of myeloid immu-
noregulatory (MIR) cells in spleen and lymph nodes.
32 33 Thus,
in major peripheral lymphoid tissues like spleen and lymph
node, SHIP-deﬁciency leads to profound and functional expan-
sion of immunoregulatory capacity. In aggregate these studies
establish that inositol phospholipid signalling plays a pivotal
role in the formation, homeostasis and function of both myeloid
and lymphoid immunoregulatory cell populations.
SHIP, through its 59-inositol phosphatase domain, hydrolyses
the second messenger PI(3,4,5)P3 and thus limits PI3K activation
of key downstream immune effector pathways such as Akt
and NF-kB.
30 40 SHIP-deﬁcient mice are smaller than their WT
and heterozygous littermates and exhibit a greatly reduced life-
span with survival beyond 10e12 weeks of life observed only
rarely,
32 41 attributable in part to the development of an eosino-
philic crystalline pneumonia with inﬁltration by mixed inﬂam-
matorycellsresultinginpatchylungconsolidation.
41Eosinophilic
crystalline pneumonia is a cause of shortened life span in various
genetically engineered mouse models.
42 43 Granulocytes are
less susceptible to apoptotic signals in SHIP-deﬁcient mice, and
granulocyteemonocyte inﬁltrations can be found in the liver,
kidney, heart, skeletal muscle, pancreas lymph nodes and
thymus.
44 The increased capacity of SHIP-deﬁcient T cells to
differentiateintoTregcellsisaccompaniedbyadeﬁciencyinTh17
cell differentiation and a reduced ability to cause colitis after
adoptive transfer of CD4
+ Tcells to Tcell deﬁcient hosts.
35 36
Although SHIP expression and function has generally been
thought to be conﬁned to cells in the haematopoietic system,
recent evidence indicates that SHIP is also expressed by some
parenchymal cell types, including osteoblasts
45 and endothelial
cells.
46 In fact, we recently identiﬁed the ﬁrst known function
for SHIP outside the haematolymphoid compartment as SHIP is
required for support of haematopoietic stem cell function and
quiescence by bone marrow (BM) niche cells.
45
Given its role in immune regulation and lymphoid function
we sought to examine whether SHIP-deﬁciency might have
consequences at enteric mucosal surfaces where greater stress is
placed on both immune effector and regulatory processes due to
the close and constant interaction with commensal microﬂora
and potential pathogens at this organ site. Surprisingly, our
analysis reveals a paucity of both CD4 and CD8 T cells in the
small intestine with a concomitant increase in neutrophils at
this site. Consistent with altered immune status we ﬁnd spon-
taneous development of ileitis with features that closely reca-
pitulate those of CD pathology. In addition, the susceptibility
factor for this CD-like ileitis of SHIP-deﬁcient mice appears to be
in the haematopoietic compartment, and likely granulocytee
monocyte, as the CD-like ileitis was transferable to an immu-
nocompetent host following irradiation and reconstitution with
SHIP splenocytes, but not following transfer of either Tcells or
natural killer (NK) cells. Consequently, the SHIP-deﬁcient mouse
is the ﬁrst CD animal model capable of adoptively transferring
CD-like disease to an immunocompetent host.
MATERIALS AND METHODS
Mice
The development and production of SHIP
 /  mice has been
described previously. In brief SHIP
 /  mice were generated by
deletion of the promoter and ﬁrst exon of SHIP via a Cre-LoxP
strategy and then backcrossed to the C57BL6/J background.
SHIPDIP/DIP mice were a kind gift of Dr Jeffery Ravetch (Rock-
efeller University, New York).
47 MxCreSHIP
ﬂox/ﬂox mice were
described previously.
33 SHIP expression is ablated in these mice
following three intraperitoneal injections of polyI/C at 625m/
dose. MxCreSHIP
ﬂox/ﬂox mice were sacriﬁced for tissue harvest
4e5 weeks after the last polyI/C injection. The PI3K haploin-
sufﬁcient SHIP
 /  mice analysed in this study possess a muta-
tion in the p85 regulatory subunit of PI3K
48 and a SHIP
mutation created by Helgason et al.
41 All mice were between
6 and 13 weeks of age at time of sacriﬁce. All mice were main-
tained in an accredited, barrier facility conﬁrmed free of
a comprehensive list of potential parasites and microbial path-
ogens including Citrobacter rodentium, Pseudomonas aeruginosa,
Salmonella spp., and Clostridium perfringens, viral Antibodies to
murine norovirus (MNV), parainﬂuenza virus type I (Sendai),
coronavirus (MHV), Mycoplasma pulmonis, paramyxovirus
(PVM), parvovirus (MPV, MMV), poliovirus (TMEV) reovirus
type 3 (Reo), arterivirus (LCM), adenovirus (MAD1, MAD2),
poxvirus (Ectro), rotavirus (EDIM), papovavirus (Poly), and free
of Helicobacter sp. by PCR screening. Further, microorganisms
were not identiﬁed in any tissue using WarthineStarry, Giemsa,
Ziehle Neelsen and PAS stains.
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Inﬂammatory bowel diseaseAdoptive transfer experiments
BM cells were ﬂushed from intact femur and tibia and collected
in tissue media (TM) consisting of RPMI, 3% fetal bovine serum
(FBS) and 10 mM HEPES (Invitrogen, Carlsbad, California,
USA). Spleens were crushed with a 10 ml syringe plunger. The
single cell suspension was then ﬁltered through a 70 mm strainer
(BD Bioscience, San Jose, CA) and red blood cell (RBC) lysis
performed at room temperature for 5 min in 13 RBC lysis buffer
(eBioscience, San Diego, California, USA). Cells were centrifuged
and resuspended in 13 Dulbecco phosphate-buffered saline
(D-PBS). C57BL/6 recipients were given antibiotic water prior to
receiving a split dose of 1100 Rads (600+500) from an x-ray
irradiator. Irradiated recipients were then transplanted with
5310
5 BM cells or splenocytes as indicated via retro-orbital
injection. For adoptive transfer of Tand NK cells, CD3
+NKp46
 
Tand NKp46
+CD3
  NK cells were simultaneously sorted from
spleens of SHIP
 /  mice and adoptively transferred into irradi-
ated C57BL6 hosts (550 Rads) via retro-orbital injection. Each
C57BL/6 host received 2.4310
5 SHIP
 /  T cells and 7.5310
3
SHIP
 /  NK cells.
Histopathological analysis
Necropsies were performed in a systematic, comprehensive
manner. The entire alimentary tract, including the oesophagus,
stomach, duodenum, jejunum, ileum, caecum, and colon and
associated mesentery and mesenteric lymph nodes was evalu-
ated, and the alimentary tract was insufﬂated with 10% neutral-
buffered formalin and rolled in segments to ﬁt as Swiss rolls into
cassettes for histological processing and microscopic evaluation.
The skin, subcutis, skeletal muscle, inguinal lymph node and
mammary fat pad, cervical lymph node, salivary glands, repro-
ductive tract and associated glands, liver, gall bladder, spleen,
pancreas, kidneys and adrenal glands, were evaluated. The
larynx, trachea with attached thyroid and parathyroid glands,
heart, thymus, and lungs insufﬂated with 10% neutral-buffered
formalin were collected. Tissues were ﬁxed in 10% neutral-
buffered formalin, dehydrated, embedded in parafﬁn, sectioned
at 3 mm and stained with H&E. Histological sections of each
segment of the alimentary tract were masked, assessed and
assigned an inﬂammatory grade of 0e6, with grade 6 repre-
senting the most progressed, severe lesion. Inﬂammatory grades
assigned were as follows: inﬂammatory grade 0¼no signiﬁcant
abnormalities; inﬂammatory grade 1¼mild predominantly
polymorphonuclear (PMN) leucocyte inﬁltrations (<25 PMN/
hpf) of the lamina propria and/or enteric lymph nodule;
inﬂammatory grade 2¼moderate predominantly PMN leucocyte
inﬁltrations (>25 cells/hpf) of the lamina propria and/or lymph
nodule; inﬂammatory grade 3¼marked inﬂammatory cell inﬁl-
trations with extension below the muscularis mucosa causing
architectural distortion of the mucosa and submucosa with
attendant crypt hyperplasia; inﬂammatory grade 4¼marked
inﬁltrations with extension into the tunica muscularis; inﬂam-
matory grade 5¼marked transmural leucocyte inﬁltrations;
inﬂammatory grade 6¼marked transmural leucocyte inﬁltra-
tions with extension into the mesentery and/or other organs. In
each section the presence of granuloma, crypt abscess, stricture,
ﬁssure, and whether dissemination of inﬂammation to other
sites had occurred was noted. Inﬂammatory scores were
compared between cohorts by one-way ANOVA. All reported
p-values are two-sided with p<0.01 considered signiﬁcant. The
sections were scored by a single, board certiﬁed veterinary
pathologist. The sections were scored by a veterinary patholo-
gist with conﬁrmation of scoring system and subsequent
gradations by a clinical pathologist.
Flow cytometry
The antibodies used for staining of cells prepared from small
intestines included CD33, CD4, CD8, CD16/32, CD62L, CD62E
and Ly6G and were obtained from BD Pharmingen (San Jose,
California, USA). Samples were acquired on a FACSCalibur and
analysed using FlowJo8. Dead cells were excluded from the
analysis following cytometer acquisition of staining data based
on exclusion of the DAPI dye.
RESULTS
Ileitis in SHIP-deﬁcient mice
Seventy-nine 6e8 week old mice, including 26 SHIP
 /  mice,
26 SHIPDIP/DIP mice, one PI3K
+/ SHIP
 /  and 26 wild type
littermates, each of both sexes were submitted to systematic,
comprehensive necropsies, with histopathological examination
oftheentireinsufﬂatedalimentarytract.Primarygastrointestinal
lesionswerepresentonlywithintheileumofSHIP-deﬁcientmice,
andconsistedofasegmentalileitis.Lesionsweregradedaccording
to the extent of inﬂammation as grade 0e6( ﬁgures 1e6). Of the
53 SHIP-deﬁcient mice evaluated, only 3 of the 53 (6%) of
SHIP-deﬁcient mice lacked ileitis, while 50 of the 53 (94%) of
SHIP-deﬁcient mice had some degree of ileitis, signiﬁcantly
more than the absence of ileitis in WT littermates (p<0.001).
Both SHIP
 /  and SHIPDIP/DIP that harbour deletions in exons
encoding different regions in the SHIP1 locus developed ileitis
with comparable frequency with 25 of 26 (96%) of SHIP
 / 
mice, and 24 of 26 (92%) of SHIPDIP/DIP mice affected with
comparable mean ileitis inﬂammatory grades of 4.262.1
and 4.062.2, respectively. Ileitis was also observed in
a PI3K
+/ SHIP
 /  mouse (grade 4), indicating that a third
independent SHIP mutant strain develops this pathology and
that PI3K haploinsufﬁciency does not protect from development
of ileitis. PI3K
+/ SHIP
+/+ and PI3K
+/ SHIP
+/  controls showed
no evidence of ileitis (grade 0). Inﬂammatory lesions of the ileum
in all SHIP-deﬁcient mice analysed were present on a background
of otherwise unaffected, uninﬂamed gastrointestinal tract.
The earliest manifestation of CD-like ileitis in SHIP-deﬁcient
mice, assigned grade 1, consisted of a mild (<25 PMN/hpf),
predominantly PMN leucocyte inﬁltration of the lamina propria
and frequently underlying lymph nodule (ﬁgure 1). The ileum of
9 of the 53 (17%) of the SHIP-deﬁcient mice had grade 1 lesions.
This mild, earliest lesion of the SHIP-deﬁcient ileum had
progressed in other individual SHIP
 /  and SHIPDIP/DIP mice to
a moderate (>25 PMN/hpf), mixed, but still predominantly
PMN leucocyte inﬁltration of the expanded lamina propria and
underlying lymph nodule, assigned grade 2, with attendant
crypt regenerative hyperplasia manifest as IEC crowding, and
elongation of crypt depth (ﬁgure 2). Grade 2 ileitis was present
in 2 of the 53 (4%) of SHIP-deﬁcient mice. Grade 3 inﬂammatory
cell inﬁltrations were mixed and penetrated below the muscu-
laris mucosa with distortion of villous architecture by the
expanded mucosa and submucosa, and attendant crypt hyper-
plasia (ﬁgure 3). Five of the 53 (9%) of SHIP-deﬁcient mice had
grade 3 inﬂammatory lesions within the ileum.
Marked, mixed inﬂammatory cell inﬁltrations of the ileum of
SHIP-deﬁcient mice extending from the mucosa, submucosa, and
into the tunica muscularis were assigned grade 4 (ﬁgure 4). Six of
the 53 (11%) of SHIP-deﬁcient mice had grade 4 inﬂammatory
lesions within the ileum. Composition of grade 4 inﬂammation
varied from predominantly PMN in some segments to
predominantly mononuclear in others, often as a mix of gran-
ulocytes, lymphocytes, histiocytes and multinucleated giant
cells (ﬁgure 4D,E). Inﬂammatory cell inﬁltrations that extended
into the tunica muscularis were segmental, sharply delimited,
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Inﬂammatory bowel diseaseand arranged either randomly or as rows of aggregates in rosary-
bead arrays (ﬁgure 4F). In some areas of grade 4 inﬂammation
the overlying mucosa was focally ulcerated. Granulomas and
pyo-granulomas were present in the mucosa, submucosa and/or
tunica muscularis. Thickening of the bowel wall due to grade 4
inﬂammation resulted in lumen narrowing and stricture
formation in some mice (ﬁgure 4G).
Marked, mixed inﬂammatory cell inﬁltrations that extended
transmural, deep into the bowel wall to the serosa, assigned
grade 5 (ﬁgure 5), were present in 5 of the 53 (9%) of SHIP-
deﬁcient mice. In some cases, grade 5 ileitis thickened the bowel
wall, narrowed the lumen, led to stricture formation and the
development of ﬁssures that penetrated into and ended blindly
within the tunica muscularis (ﬁgure 5A,B).
SHIP-deﬁcient mice with marked, mixed, transmural inﬂam-
matory cell inﬁltrations of the ileum that extended by way of
ﬁssures through the thickened tunica muscularis and serosa into
the mesentery (ﬁgure 6AeC) were assigned grade 6. More SHIP-
deﬁcient mice were assigned inﬂammatory grade 6 than any
other grade with 23 of the 53 (43%) of SHIP-deﬁcient mice
assigned ileitis grade 6. Inﬂammation extending into the
mesentery consisted of mixed inﬂammatory cells, granuloma,
ﬁbrosis, and rarely thrombosis and vasculitis (ﬁgure 6DeF).
Ileitis of SHIP-deﬁcient mice of all grades 1e6 was segmental,
presenting either as focal, discontinuous inﬂammatory cell
inﬁltrations or as broad bands of inﬂammation within the ileum
(ﬁgure 7AeC). Neighbouring segments of ileum and those of
more proximal small intestine or distal large intestine were
unaffected. Strictures were observed in 12 of 53 (23%) of SHIP-
deﬁcient mice (ﬁgure 4G), granuloma were present in 15 of 53
(28%) (ﬁgure 4I), and crypt abscesses were observed in 5 of 53
(9%) of SHIP-deﬁcient mice (ﬁgure 4J). Pyloric metaplasia of the
ileum, and ﬁstula formation, other characteristics of CD histo-
pathology in humans, were not evident in SHIP-deﬁcient mice.
Rarely, ileitis spread by direct extension to other gastrointes-
tinal sites, including in two mice where inﬂammation of the
ileum extended via the mesentery to the colon wall (ﬁgure 8A,B),
and in a third SHIP-deﬁcient mouse where inﬂammation had
spreadto thegastro-oesophageal juncture(ﬁgure8C,D). Draining
mesentericlymphnodeswereoftenenlargedandinﬂamedin33of
53 (62%) of SHIP-deﬁcient mice (ﬁgure 8E,F). An individual
SHIP
 /  mouse had inﬂammatory cellular thrombi in mesenteric
veins and a granulomatous pulmonary consolidation comparable
in composition to the ileitis in this case, suggesting that vascular
thrombi and emboli may rarely develop as a consequence of
CD-like ileitis in SHIP-deﬁcient mice and may disseminate
inﬂammation via haematogenous routes (ﬁgure 8GeJ). This
pulmonary consolidation was distinct from that which occurs
routinely in SHIP
 /  and SHIPDIPDIP mice as an eosinophilic
crystalline pneumonia (ﬁgure 9AeF).
Figure 1 Grade 1 Crohn’s disease
(CD)-like ileitis of SHIP-deﬁcient mice.
Longitudinal sections through Swiss
rolls of small intestine from SHIP-
deﬁcient mice with early manifestations
of CD-like disease, interpreted as grade
1, with mild predominantly
polymorphonuclear (PMN) leucocyte
inﬁltration of the lamina propria (B,
arrows). This PMN inﬁltration of the
ileum was typically present in the
mucosa overlying and within lymph
nodules (CeF). Adjacent ileum and
more proximal small intestine (C,
asterisk) were unaffected with normal
villous mucosal architecture. Higher
magniﬁcations show a predominantly
PMN leucocyte inﬁltration of the villous
lamina propria (F), and within the
underlying lymph nodule, in this case
accompanied by histiocytes and
multinucleated giant cells (E).
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Inﬂammatory bowel diseaseIlietis results following ablation of SHIP expression in adulthood
The above studies show that ileitis occurs in germline SHIP
mutant mice, indicating this CD-like pathology may have
a developmental origin. To test this possibility we analysed
intestinal pathology in MxCreSHIP
ﬂox/ﬂox mice where SHIP
expression is normal in fetal, neonatal and adolescent life, but
can be ablated during adulthood following polyI/C administra-
tion.
33 This approach results in eosinophilic crystalline pneu-
monia in adult mice rendered SHIP deﬁcient.
49 For this analysis
twelve 6e8 week old MxCreSHIP
ﬂox/ﬂox mice and twelve
SHIP
ﬂox/ﬂox controls, each of both sexes were submitted to
comparable histopathological analyses. Primary gastrointestinal
lesions were present only within the ileum of MxCreSHIP
ﬂox/ﬂox
mice, while SHIP
ﬂox/ﬂox mice were unaffected 4e5 weeks after
the last injection of polyI/C. Of the 12 MxCreSHIP
ﬂox/ﬂox mice
evaluated, only 1 (8%) lacked ileitis, while 11 of 12 (92%)
developed ileitis with a mean inﬂammatory grade of 3.561.9.
Comparable to ileitis of SHIP
 /  and SHIPDIP/DIP mice, ileitis of
MxCre SHIP ﬂox/ﬂox mice was segmental in nature with mixed
inﬂammatory cell inﬁltrations. Granuloma formation was
evident in 2 of 12 (17%) of MxCreSHIP
ﬂox/ﬂox mice. Thus,
CD-like ileitis develops with selective deletion in adult mice,
illustrating that SHIP expression is required to maintain normal
mucosal immune homeostasis and regulation in the adult ileum.
SHIP-deﬁcient parenchymal cells do not cause ileitis
To assess the possibility that SHIP-deﬁciency might alter the
development or function of parenchymal cell types in the ileum
such as the IEC, we created bone marrow (BM) chimeras where
six SHIP
 /  hosts were reconstituted with WT C57BL/6 BM
and analysed histopathologically 4 months post-transplantation.
The gastrointestinal tract of the six SHIP
 /  hosts reconstituted
with WT BM lacked any abnormalities including all features of
the CD-like ileitis observed in germline SHIP
 /  and SHIPDIP/DIP
mice. We also analysed the lungs of these reconstituted mice.
Although components of a moderate eosinophilic crystalline
pneumonia werepresent in theSHIP
 /  hostsreconstituted with
WT C57BL/6 BM, including crystal formation, and an increase in
the number of alveolar macrophages, the marked myeloid inﬁl-
tration and pulmonary consolidation observed in SHIP
 /  and
Figure 3 Grade 3 Crohn’s disease-like ileitis of SHIP-deﬁcient mice was comprised of a marked, mixed, often predominantly polymorphonuclear
(PMN) inﬂammatory cell inﬁltration of the ileum with expansion of the mucosa and submucosa (A, bracketed arrows), loss of normal villous
architecture, and crypt elongation (A, arrow). Higher magniﬁcations of the affected ileum (B, C) showed a mixed, predominantly PMN leucocyte
inﬁltration.
Figure 2 Grade 2 Crohn’s disease-like
ileitis of SHIP-deﬁcient mice was
comprised of a moderate, mixed,
predominantly polymorphonuclear
leucocyte inﬁltration of the ileum lamina
propria (D) and underlying lymph nodule
(C), with attendant crypt hyperplasia (B,
upper bracketed arrows) with
elongation, crowding, and numerous
mitotic ﬁgures (D), compared to the
unaffected mucosa of the adjacent small
intestine (A, asterisk) with normal
villous architecture and typical crypt
depth (B, lower bracketed arrows).
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Inﬂammatory bowel diseaseSHIPDIP/DIP mice was not present in lungs of SHIP
 /  hosts
reconstituted with WT C57BL/6 BM.
SHIP-deﬁcient haematolymphoid cells transfer ileitis to WT hosts
To directly test whether SHIP-deﬁcient haematolymphoid cells
are responsible for the ileitis observed in SHIP-deﬁcient strains,
we adoptively transferred 5310
5 SHIP
 /  splenocytes to each of
six WT C57BL/6 hosts. The lungs and intestines were then
analysed 1 month later for evidence of pathology. Segmental
ileitis similar to that observed in germline SHIP-deﬁcient mice
was present in 5 of 6 WT mice that received SHIP
 /  spleno-
cytes with a mean ileitis score of 1.8 (the range of scores was
0e5). This analysis demonstrates that SHIP-deﬁciency of the
haematolymphoid compartment is sufﬁcient to alter enteric
immune cell homeostatic responses in the small intestine
resulting in a CD-like phenotype. Interestingly, adoptive transfer
Figure 4 Grade 4 Crohn’s disease-like ileitis of SHIP-deﬁcient mice was comprised of a marked, mixed inﬂammatory cell inﬁltration of the ileum
extending through the mucosa, submucosa, and into the tunica muscularis (A, B, C, F, G). Such inﬂammatory cell inﬁltrations varied in composition,
were in some areas of affected ileum predominantly polymorphonuclear (D), while in other areas were predominantly mononuclear with lymphocytes,
histiocytes and numerous multi-nucleated giant cells present (B, E). Grade 4 ileitis was typically sharply delimited aggregates of pyo-granulomatous
inﬂammatory cell inﬁltrations, at times in rosary-bead arrays (F, arrows), that caused thickening of the bowel wall (G, arrows) and lumen narrowing.
Multinucleated giant cells (H), and pyo-granulomas (I) were frequently present in affected segments, but crypt abscesses (J, arrow) were less
frequently observed.
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Inﬂammatory bowel diseaseFigure 5 Grade 5 Crohn’s disease-like ileitis of SHIP-deﬁcient mice consisted of marked, mixed, transmural inﬂammatory cell inﬁltrations that
extended to the serosa, some of which due to bowel wall thickening and stricture formation had developed ﬁssures that penetrated into and ended
blindly within the tunica muscularis (A; B, arrow).
Figure 6 Most SHIP-deﬁcient mice presented with grade 6 Crohn’s disease-like ileitis which consisted of marked, mixed, transmural inﬂammatory
cell inﬁltrations that extended by way of ﬁssures through the ileum serosa into the mesentery (AeC, arrows), the inﬂammation of which was
comprised of mixed inﬂammatory cells and ﬁbroblasts in aggregates and whirls (E), and pyo-granuloma, some with central necrosis (F, arrow).
Figure 7 Segmental nature of Crohn’s disease-like ileitis of SHIP-deﬁcient mice comprised of either discrete, discontinuous foci of inﬂammation (A,
arrows), or broad bands of inﬂammation (B, bracketed arrows), each with expansion of the mucosa and submucosa, and thickening of the tunica
muscularis (C, left arrow) compared to neighbouring unaffected segments (C, right arrow; A, B, C, asterisks) with normal villous architecture and bowel
wall thickness.
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Inﬂammatory bowel diseaseFigure 8 Inﬂammation extended
beyond the ileum in a few SHIP-deﬁcient
mice where mixed leucocyte inﬁltrations
of the mesentery inﬁltrated into the
colon wall (A, arrow; B), or the juncture
of the oesophagus and stomach (C,
arrows; D). Draining mesenteric lymph
nodes were frequently enlarged and
consisted of mixed inﬂammatory cells
with numerous multinucleate cells (E,
F). Rarely, inﬂammatory cellular thrombi
(T) were present within mesenteric
veins (G, H, arrows), and as emboli may
have lodged in pulmonary
microvasculature resulting in
a granulomatous pulmonary
consolidation comprised of mixed
inﬂammatory cells with numerous
multinucleate cells (I, J, left) that
contrasted sharply with the eosinophilic
crystalline pneumonia of neighbouring
lobes (I, J, right) typical of SHIP-
deﬁcient mice.
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Inﬂammatory bowel diseaseof FACS-puriﬁed CD3
+ Tcells, NK1.1
+CD3
  NK cells prepared
from the spleens of SHIP
 /  mice was unable to transfer any
detectable ileitis to WT hosts (three hosts analysed per cell
type). Thus, SHIP-deﬁcient T cells or NK cells are sufﬁcient for
transfer of ileitis. We also observed that SHIP
 /  splenocytes
transfer a mild to moderate eosinophilic crystalline pneumonia
to WT hosts with progression to patchy pulmonary consolida-
tion in some cases as is observed in both germline SHIP-
deﬁcient mice
41 and MxCreSHIP
ﬂox/ﬂox mice following gene
ablation.
49
Neutrophilia combined with T cell paucity in the SHIP-deﬁcient
small intestine
Our pathology ﬁndings and adoptive transfer studies described
above suggest that a granulocyteemonocyte lineage cell may
underlie the ileitis that we observe in SHIP-deﬁcient mice. To
further evaluate this possibility, we conducted multi-parametric
cytometry assays of major immune cell populations including
neutrophils, dendritic cells, CD4/CD8 T cells and Treg cells
present in small intestines of SHIP-deﬁcient and WT mice. In
support of a role for neutrophils in ileitis, we ﬁnd there is an
absolute increase in total number of neutrophils present in the
small intestine of SHIP
 /  mice (ﬁgure 10). This applied to
neutrophils of the Ly6G
+CD16/32
+ phenotype as well as
the CD62L
+ subset (ﬁgure 10 A,B). These ﬁndings of ileal
neutrophilia are consistent with our histopathology studies
described above. Surprisingly, we ﬁnd a profound reduction in
the number of both CD4 (ﬁgure 11A) and CD8 (ﬁgure 11B)
T cells present in SHIP-deﬁcient small intestines. When paired
with the T cell adoptive transfer studies described above, these
ﬁndings suggest that the CD-like ileitis observed in SHIP-deﬁ-
cient mice is not attributable to an autoimmune attack by SHIP-
deﬁcient T cells. Analysis of CD11c
+CD11b
+ mature dendritic
cells and CD4
+CD25
+ Treg cells did not show a signiﬁcant
difference in the numbers of these immune cells between
SHIP
 /  and WT small intestines.
DISCUSSION
CD pathology begins with the formation of multiple aphthoid
ulcers inﬁltrated by neutrophils, which progress and coalesce
into sharply delimited, regional, transmural inﬂammations with
formation of strictures, ﬁssures and ﬁstulas.
1e4 Here we show
that mutation of the SHIP1 locus leads to a comparable ileitis
dominated by neutrophils. Although elements of CD pathology
are lacking in the SHIP-deﬁcient mouse described herein,
including development of multiple aphthoid ulcers, pyloric gland
metaplasia, granulation tissue, and ﬁstula formation, many CD
histopathological features are present. SHIP-deﬁcient ileitis is
not precipitated by an apparent dysfunction on the part of SHIP-
deﬁcient parenchymal elements as reconstitution of SHIP
 / 
Figure 9 SHIP-deﬁcient mice develop
an eosinophilic crystalline pneumonia
that consists of large crystals in
bronchiolar airways, foci of mixed
inﬂammatory cell inﬁltrations (A, arrow),
bronchiolar subepithelial ﬁbrosis (B,
arrows), hypertrophy and mucous
metaplasia of bronchiolar epithelium (C),
numerous alveolar macrophages and
multinucleate cells (D, E), and inﬁltrating
leucocytes resulting in patchy
pulmonary consolidation (F, left).
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Inﬂammatory bowel diseasehosts with SHIP-competent haematolymphoid cells prevents
development of ileitis. However, these same hosts still retain
some facets of eosinophilic crystalline pneumonia indicating
that SHIP
 /  parenchymal elements may contribute to the lung
pathology found in germline SHIP-deﬁcient mice. Conversely,
we ﬁnd that transfer of SHIP-deﬁcient haematolymphoid cells
from the spleen is sufﬁcient to trigger CD-like ileitis in an
immunocompetent host. Transfer of cells capable of a cell-
mediated immune attack, Tcells and NK cells, do not elicit this
CD-like ileitis. These ﬁndings suggest that a SHIP-deﬁcient
myeloid cell may promote the CD-like enteritis that occurs in
SHIP-deﬁcient mice. Granulocytes are less susceptible to
apoptotic signals in SHIP-deﬁcient mice, granulocyteemonocyte
inﬁltrations can be found in various tissues of SHIP-deﬁcient
mice,
44 and mononuclear phagocytes are essential for mainte-
nance of intestinal homeostasis.
50
Retention of components of eosinophilic crystalline pneu-
monia in the SHIP
 /  hosts reconstituted with WT BM indi-
cates that aspects of this lung pathology are of a parenchymal,
cell autonomous origin. Mass spectrometry analyses have iden-
tiﬁed Ym1 as the principal crystalline protein of this pneumonia,
perhaps secreted by activated alveolar macrophages, and
proposed to be involved in eosinophil recruitment, immune
activation and tissue repair.
34 However, since SHIP-deﬁcient
mice that undergo allogeneic BM transplant have a normal
lifespan,
32 these retained features of pulmonary pathology are
apparently not sufﬁcient to progress to the fatal lung consoli-
dation that occurs in germline, SHIP-deﬁcient mice.
41 Further,
with the present observations, CD-like enteritis should be
included among the pathologies that develop and contribute to
morbidity and mortality in germline, SHIP-deﬁcient mice.
The absence of enteric pathology in SHIP
 /  hosts recon-
stituted with WT BM indicates that SHIP-deﬁciency does not
cause an IEC functional barrier defect leading to ileitis.
Conversely, that the CD-like phenotype can be transferred to an
immunocompetent host by SHIP-deﬁcient haematopoietic cells
suggests that SHIP-deﬁcient ileitis is due to an alteration in the
regulation of innate immune functions (eg, granulocytee
monocyte responses), a failure of Tcell mediated mucosal barrier
functions or a combination of such potential alterations. Ileitis
in SHIP-deﬁcient mice may result from a deﬁcit in mucosal Tcell
function that permits inappropriate granulocyteemonocyte
responses to commensal organisms and luminal antigens
culminating in the inﬂamed states observed in the ileum of
SHIP-deﬁcient mice.
Although the SAMP1/Yit mouse
24 and the TNF
ΔARE mouse
25
spontaneously develop ileitis, the present SHIP-deﬁcient mouse
is unique in that it recapitulates the CD phenotype apparently
through perturbation of immune cell populations that can be
transferred to a WT host. There are a number of possible
candidates for the enteritis-inducing cell. Because we observed
neutrophilic inﬁltrates in the distal ileum lamina propria of most
SHIP-deﬁcient mice, we speculate that inappropriate responses
by neutrophils to commensal microﬂora in the lumen of the
ileum may underlie or trigger the immune attack. SHIP plays
a pivotal role in preventing neutrophilia, as granulocyte numbers
in peripheral blood are profoundly increased in SHIP
 /  mice
41
as well as mice treated with a SHIP1 selective inhibitor, 3AC.
49
Inappropriate effector function by SHIP
 /  neutrophils at organ
Figure 10 Neutrophilia in SHIP-deﬁcient small intestine. FACS
detection of CD16/32
+Ly6G
+ neutrophils (A) and their CD62L/E surface
staining (B) in small intestine of SHIP-deﬁcient mice and wild-type (WT)
littermates. (C) Absolute total CD16/32
+Ly6G
+ neutrophils and CD62L
+
neutrophils in the small intestine of SHIP-deﬁcient and WT mice as
indicated. ***p<0.001.
Figure 11 Profound T cell deﬁcit in SHIP-deﬁcient small intestine.
FACS detection of CD3
+CD4
+ (A) and CD3
+CD8
+ (B) T cells in the
small intestine of SHIP-deﬁcient mice and their wild-type (WT)
littermates. (C) Absolute CD4 and CD8 T cell numbers in the small
intestine of SHIP-deﬁcient and WT mice as indicated. **p<0.01.
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Inﬂammatory bowel diseasesites has not been examined to date, and thus our ﬁndings
represent the ﬁrst indication of neutrophil-mediated tissue
damage in SHIP-deﬁcient hosts. Conversely, it seems unlikely
that the enteritis results from inappropriate Tcell attack in the
small intestine, as SHIP-deﬁciency causes a profound local deﬁcit
in both CD4 and CD8 T cell numbers in the small intestine,
while normal numbers of Treg cells are still present at this site.
TheCD-likepathologicalﬁndingsdescribedaboveareroutinely
observed in the ileum of both SHIP
 /  strains
31 41 and the
SHIPDIPDIPstrain
47thatharbourdifferentmutationsoftheSHIP1
gene indicating this is a highly penetrant phenotype. Moreover,
because the phenotype occurs in the SHIPDIPDIPstrain where only
the inositol phosphatase domain encoding exons of SHIP are
excised, we conclude that the phenotype is dependent on loss of
SHIP enzymatic activity. SHIP through its 59-inositol phospha-
tase domain hydrolyses the second messenger PI(3,4,5)P3 and
thus limits PI3K activation of key downstream survival and
effector pathways promoted by Akt and NF-kB.
30 40 However,
recent ﬁndings indicate that SHIP, via generation of PI(3,4)P2, can
also promote cellular survival by increasing activation of Akt,
49
consistent with the demonstration that Akt binds to and is more
effectively activated by the SHIP product, PI(3,4)P2, than by its
substrate, PI(3,4,5)P3.
51 Tiwari et al found that SHIP can also
promote immune effector function via synthesis of PI(3,4)P2.
52 It
remains to be determined whether SHIP-deﬁciency is causing
ileitis due to a lack of inhibitory or activating signalling in
immune cells. This may be dependent on cellular context. For
instance, one could envision that SHIP may be required for efﬁ-
cient mucosal trafﬁcking and survival of Tcells via generation of
PI(3,4)P2, but by decreasing PI(3,4,5)P3 in neutrophils SHIP is also
limiting their numbers and function at this enteric site. Future
lineage speciﬁc SHIP ablation studies using SHIP
ﬂox/ﬂox mice and
appropriate Cre transgenes combined with biochemical analysis
PI3K effector pathways in these models may elucidate the
molecular mechanism underlying SHIP’s role in preserving
normal immune function/regulation in the ileum.
Genetic analysis of mice and genome wide association studies
have led to the identiﬁcation of mutations that can predispose to
CD with varying probability of incidence and timing of onset.
Our analysis suggests that in the laboratory mouse, SHIP is
a strong genetic determinant of CD-like pathology, suggesting
that a similar situation may also be revealed by close examina-
tion of SHIPexpression and function in CD patients. Tantalising
evidence for a role of SHIP1 in human IBD is suggested by the
recent demonstration that a chromosome 2 polymorphism
located at 2q37 is associated with a signiﬁcantly increased and
early onset of IBD.
53 The SHIP1 locus is also found in the 2q37
region of human chromosome 2. This potential association
merits comparison of SHIP enzymatic activity in IBD patients
and normal controls using a recently developed ﬂuorogenic assay
that measures SHIP1 activity.
49 Future investigations of cellular
and molecular mechanisms responsible for ileitis in SHIP-deﬁ-
cient mice may also provide insights into how immunological
alterations contribute to IBD.
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